Borgman Anne Elizabeth

CIK 00018863883 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001886388

Recent Transactions

31 trades

Award
CURIS INC$CRIS
Non Qualified Stock Option
2026-07-07$5.29/sh+6,800→ 6,800 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2026-06-18+2,340→ 2,340 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2025-06-20+18,700→ 18,700 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2025-05-20$3.13/sh+14,400→ 14,400 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-05-01−15,938→ 17,812 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-05-01+53,125→ 106,223 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-05-01+15,938→ 122,161 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-05-01$1.07/sh−24,709→ 97,452 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-05-01−53,125→ 21,875 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-03-01$1.59/sh−4,621→ 53,098 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-03-01+11,250→ 57,719 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-03-01−11,250→ 33,750 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2025-02-28−37,500→ 75,000 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-02-28+37,500→ 61,874 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2025-02-28$1.59/sh−15,405→ 46,469 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2025-01-28$3.13/sh+1,600→ 1,600 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2024-06-20+18,700→ 18,700 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2024-05-21$11.62/sh+4,250→ 4,250 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (Right to Buy Common Stock)
2024-03-05+60,000→ 60,000 total
Award
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Units (RSUs)
2024-03-05+45,000→ 45,000 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-02-29+37,500→ 37,500 total
Tax Payment
SUTRO BIOPHARMA, INC.$STRO
Common Stock
2024-02-29$4.91/sh−13,126→ 24,374 total
Exercise/Conversion
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2024-02-29−37,500→ 112,500 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2023-06-22+14,250→ 14,250 total
Award
SUTRO BIOPHARMA, INC.$STRO
Stock Option (right to buy Common Stock)
2023-03-15+175,000→ 175,000 total
Award
SUTRO BIOPHARMA, INC.$STRO
Restricted Stock Unit (RSU)
2023-03-15+150,000→ 150,000 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2023-01-23+85,000→ 85,000 total
Award
CURIS INC$CRIS
Non Qualified Stock Option
2022-10-12+25,000→ 25,000 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2022-06-23+14,250→ 14,250 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2021-10-01+10,384→ 10,384 total
Award
NextCure, Inc.$NXTC
Stock Option (Right to Buy)
2021-10-01+28,500→ 28,500 total

Companies

Recent Filings

Address

128 SPRING STREET BUILDING C - SUITE 500

LEXINGTON, MA, 02421

View on SEC.gov